CVD risk in the moderate-to-low declining cardiovascular health (CVH) group was 9.96 times that of the persistently high CVH ...

This chart shows the share of respondents in a selection of countries who said they suffer from cardiovascular diseases.

Heart disease is already the world's leading cause of death, and the addition of a new, invisible pollutant could make ...

Longitudinal patterns of change in CVH through young adulthood were associated with the risk for incident CVD in later life.

An expert discusses the growing burden of atherosclerotic cardiovascular disease (ASCVD) in the U.S., emphasizing the ...

An expert discusses how chronic kidney disease (CKD), often underdiagnosed and poorly recognized, is intricately linked with cardiovascular and metabolic conditions, emphasizing the urgent need for ...

Adults with worse cardiovascular-kidney-metabolic health are at an increased risk of developing psoriasis, especially in those with high genetic risk.

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Menopause is not just a hormonal transition; it's a turning point for heart health. Dr Shweta Mendiratta explains how ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

Coronary artery calcium (CAC) is a marker of subclinical atherosclerosis that confers increased risk of atherosclerotic cardiovascular disease. Measured by noncontrast cardiac computed tomography, CAC ...

Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...